A007575 Stock Overview
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Ilyang Pharmaceutical Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩15,150.00 |
52 Week High | ₩19,400.00 |
52 Week Low | ₩14,350.00 |
Beta | -0.27 |
1 Month Change | -2.20% |
3 Month Change | -0.53% |
1 Year Change | -19.88% |
3 Year Change | -62.03% |
5 Year Change | -27.16% |
Change since IPO | 78.24% |
Recent News & Updates
Recent updates
Shareholder Returns
A007575 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | -1.0% | 2.6% | 0.8% |
1Y | -19.9% | 6.8% | 6.3% |
Return vs Industry: A007575 underperformed the KR Pharmaceuticals industry which returned 7% over the past year.
Return vs Market: A007575 underperformed the KR Market which returned 6.6% over the past year.
Price Volatility
A007575 volatility | |
---|---|
A007575 Average Weekly Movement | 3.1% |
Pharmaceuticals Industry Average Movement | 4.5% |
Market Average Movement | 5.1% |
10% most volatile stocks in KR Market | 11.7% |
10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A007575 has not had significant price volatility in the past 3 months.
Volatility Over Time: A007575's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1946 | 655 | Dong-Yeon Kim | www.ilyang.co.kr |
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages.
Ilyang Pharmaceutical Co.,Ltd Fundamentals Summary
A007575 fundamental statistics | |
---|---|
Market cap | ₩248.01b |
Earnings (TTM) | -₩2.51b |
Revenue (TTM) | ₩370.54b |
0.7x
P/S Ratio-99.0x
P/E RatioIs A007575 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A007575 income statement (TTM) | |
---|---|
Revenue | ₩370.54b |
Cost of Revenue | ₩170.52b |
Gross Profit | ₩200.02b |
Other Expenses | ₩202.52b |
Earnings | -₩2.51b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -139.46 |
Gross Margin | 53.98% |
Net Profit Margin | -0.68% |
Debt/Equity Ratio | 32.0% |
How did A007575 perform over the long term?
See historical performance and comparison